Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch

Allergen Capture by DCs during epicutaneous immunotherapy is Enhanced by Modulating the Dose and the Surface Area of the Patch

Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB257-AB257
Hauptverfasser: Wavrin, Sophie, Mondoulet, Lucie, Dioszeghy, Vincent, PhD, Puteaux, Emilie, Ligouis, Melanie, Dhelft, Véronique, Plaquet, Camille, Dupont, Christophe M., MD, PhD, Benhamou, Pierre-Henri, Sampson, Hugh A., MD, FAAAAI
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Immunotherapy
Rodents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale Epicutaneous immunotherapy for the treatment of food allergy is effective and safe in animal models and in humans, as recently shown in a Phase II trial demonstrating the crucial role of the dose.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.827